IP Library Granted Patent US 7,736,327
Granted Patent B2
US 7,736,327 · App. 12/149,901 · Granted Jun 15, 2010

Methods and conduits for flowing blood from a heart chamber to a blood vessel

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,736,327
App. No.
12/149,901
Granted
Jun 15, 2010
Kind
B2
Abstract

Disclosed is a conduit that provides a bypass around an occlusion or stenosis in a coronary artery. The conduit is a tube adapted to be positioned in the heart wall to provide a passage for blood to flow between a heart chamber and a coronary artery, at a site distal to the occlusion or stenosis. The conduit has a section of blood vessel attached to its interior lumen which preferably includes at least one naturally occurring one-way valve positioned therein. The valve prevents the backflow of blood from the coronary artery into the heart chamber.

Claims (57)

1. A method of flowing blood from a left ventricle to an arterial blood-containing vessel, the method comprising:

placing a conduit adjacent the left ventricle and the arterial blood-containing vessel such that upon implantation of the conduit a first end of the conduit is continuously open towards the left ventricle, a second end of the conduit is continuously open towards and positioned in the arterial blood-containing vessel, and at least a portion of the first open end faces at least a portion of the second open end, wherein the conduit has a substantially lattice structure adjacent each of the first and second ends and extending therebetween; and

during diastole, restricting a flow of blood from the arterial blood-containing vessel to the left ventricle via a valve attached to the conduit within an interior of the conduit between the first and second ends.

2. The method of claim 1 , further including enlarging an opening between the left ventricle and the arterial blood-containing vessel and placing the conduit within the opening after enlarging the opening.

3. The method of claim 1 , further including inhibiting migration of the conduit via at least one of a hook, a barb, or a collar of the conduit.

4. The method of claim 1 , further including placing the conduit onto a catheter so that the conduit is in a compressed state, and introducing the catheter into an aorta.

5. The method of claim 1 , wherein the valve is an aortic valve.

6. The method of claim 1 , wherein the valve is formed from tissue engineering techniques.

7. The method of claim 1 , wherein the valve is obtained from a nonhuman animal.

8. The method of claim 1 , wherein the first end is a distalmost end of the conduit and the second end is a proximalmost end of the conduit.

9. The method of claim 8 , wherein each of the distalmost and the proximalmost ends is expandable.

10. The method of claim 1 , wherein the first end of the conduit is positioned in the left ventricle.

11. The method of claim 1 , wherein the conduit is a metal conduit.

12. The method of claim 1 , wherein the conduit includes a longitudinal axis that is substantially straight between the first and second ends.

13. The method of claim 1 , wherein a section of tissue is further attached within the interior of the conduit adjacent the first end.

14. A method of flowing blood from a left ventricle to an arterial blood-containing vessel, the method comprising:

placing a conduit adjacent the left ventricle and the arterial blood-containing vessel such that a first end of the conduit is continuously open towards the left ventricle and a second end of the conduit is continuously open towards and positioned in the arterial blood-containing vessel, wherein the conduit includes a longitudinal axis that is substantially straight between the first and second ends and wherein the conduit includes a substantially lattice structure adjacent each of the first and second ends and extending therebetween; and

during diastole, restricting a flow of blood from the vessel to the left ventricle via a valve attached to the conduit within an interior of the conduit between the first and second ends.

15. The method of claim 14 , further including enlarging an opening between the left ventricle and the arterial blood-containing vessel and placing the conduit within the opening after enlarging the opening.

16. The method of claim 14 , further including inhibiting migration of the conduit via at least one of a hook, a barb, or a collar of the conduit.

17. The method of claim 14 , further including placing the conduit onto a catheter so that the conduit is in a compressed state, and introducing the catheter into an aorta.

18. The method of claim 14 , wherein the valve is an aortic valve.

19. The method of claim 14 , wherein the valve is formed from tissue engineering techniques.

20. The method of claim 14 , wherein the valve is obtained from a nonhuman animal.

21. The method of claim 14 , wherein the first end is a distalmost end of the conduit and the second end is a proximalmost end of the conduit.

22. The method of claim 21 , wherein each of the distalmost and the proximalmost ends is expandable.

23. The method of claim 14 , wherein the first end of the conduit is positioned in the left ventricle.

24. The method of claim 14 , wherein the conduit is a metal conduit.

25. A method of flowing blood from a left ventricle to an arterial blood-containing vessel, the method comprising:

placing a metal conduit adjacent the left ventricle and the arterial blood-containing vessel such that a first end of the conduit is continuously open towards the left ventricle, a second end of the conduit is continuously open towards and positioned in the arterial blood-containing vessel, and a substantially straight line intersects at least a portion of the first end and at least a portion of the second end; and

during diastole, restricting a flow of blood from the arterial blood-containing vessel to the left ventricle via a tissue valve attached within an interior of the conduit such that the tissue valve is between the first and second ends, wherein a section of tissue is further attached within the interior of the conduit adjacent the first end.

26. The method of claim 25 , further including enlarging an opening between the left ventricle and the arterial blood-containing vessel and placing the conduit within the opening after enlarging the opening.

27. The method of claim 25 , further comprising inhibiting migration of the conduit via at least one of a hook, a barb, or a collar of the conduit.

28. The method of claim 25 , further including placing the conduit onto a catheter so that the conduit is in a compressed state, and introducing the catheter into an aorta.

29. The method of claim 25 , wherein the tissue valve is an aortic valve.

30. The method of claim 25 , wherein the tissue valve is not a naturally occurring valve.

31. The method of claim 25 , wherein the tissue valve is formed from tissue engineering techniques.

32. The method of claim 25 , wherein the tissue valve is obtained from a nonhuman animal.

33. The method of claim 25 , wherein the first end is a distalmost end of the conduit and the second end is a proximalmost end of the conduit.

34. The method of claim 33 , wherein each of the distalmost and the proximalmost ends is expandable.

35. The method of claim 25 , wherein the conduit includes a longitudinal axis and the first and second ends intersect the longitudinal axis.

36. The method of claim 25 , wherein the first end of the conduit is positioned in the left ventricle.

37. The method of claim 36 , further including enlarging an opening between the left ventricle and the arterial blood-containing vessel and placing the conduit within the opening after enlarging the opening.

38. The method of claim 36 , further including inhibiting migration of the conduit via at least one of a hook, a barb, or a collar of the conduit.

39. The method of claim 36 , further including placing the conduit onto a catheter so that the conduit is in a compressed state and introducing the catheter into the aorta.

40. The method of claim 36 , wherein the tissue valve is an aortic valve.

41. The method of claim 36 , wherein the tissue valve is not a naturally occurring valve.

42. The method of claim 36 , wherein the tissue valve is formed from tissue engineering techniques.

43. The method of claim 36 , wherein the tissue valve is obtained from a nonhuman animal.

44. The method of claim 36 , wherein the first end is a distalmost end of the conduit and the second end is a proximalmost end of the conduit.

45. The method of claim 44 , wherein each of the distalmost and the proximalmost ends is expandable.

46. The method of claim 36 , wherein the conduit includes a longitudinal axis and the first and second ends intersect the longitudinal axis.

47. A method of flowing blood from a left ventricle to an arterial blood-containing vessel, the method comprising:

placing a metal conduit adjacent the left ventricle and the arterial blood-containing vessel, such that upon implantation of the conduit a first end of the conduit is continuously open towards the left ventricle and the a second end of the conduit is continuously open towards and positioned in the arterial blood-containing vessel, wherein the conduit includes a longitudinal axis that is substantially straight between the first and second ends;

during systolic contraction of the left ventricle, permitting oxygenated blood to flow from the left ventricle to the arterial blood-containing vessel; and

during diastole, restricting a flow of blood from the arterial blood-containing vessel to the left ventricle via a tissue valve attached within an interior of the conduit such that the tissue valve is between the first and second ends, wherein a section of tissue is further attached within the interior of the conduit adjacent the first end.

48. The method of claim 47 , wherein the first end of the conduit is positioned in the left ventricle.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2024
From: WILK, PETER J.; PHELPS, DAVID Y.; WOLF, SCOTT J.
To: PERCARDIA, INC.
Reel/Frame 067358/0483 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 28, 2022
From: JENAVALVE TECHNOLOGY, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 058894/0788 →
RELEASE OF SECURITY INTEREST Recorded Jan 21, 2022
From: KREOS CAPITAL V (UK) LIMITED
To: JENAVALVE TECHNOLOGY, INC.
Reel/Frame 058802/0452 →
SECURITY INTEREST Recorded Dec 4, 2018
From: JENAVALVE TECHNOLOGY, INC.
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 048325/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2016
From: JVT RESEARCH & DEVELOPMENT CORPORATION
To: JENAVALVE TECHNOLOGY, INC.
Reel/Frame 038276/0168 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2016
From: JENAVALVE TECHNOLOGY GMBH
To: JVT RESEARCH & DEVELOPMENT CORPORATION
Reel/Frame 038279/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2014
From: JENAVALVE TECHNOLOGY, INC.
To: JENAVALVE TECHNOLOGY GMBH
Reel/Frame 033084/0369 →